wytcote senior care
We leverage the internet of things so your company can communicate wirelessly in a safe and secure network.
wytcote back to work
Let us build a solution for your unique needs.

Rapid Point of Care (POC) Antigen Test

WytCote Wellness allows effective screening of COVID-19 infection on a large scale with its 10-minute POC test kit without the need of additional equipment .
US Made Antigen test kit

Product Features

Results within 10 minutes.
USA manufactured, lateral flow assay.
Minimum invasive specimen collection (nasopharyngeal).
No equipment required.
Intended at POC setting by medical professionals.
Identify acute infection with 100% specificity and 88% sensitivity.
Detects SARS-CoV-2 nucleocapsid protein antigen.
Also available for use with a CLIA Waiver
Only 48 hours required to move large orders.
The CareStart™ COVID-19 Antigen test received the 
FDA Letter of Authorization on October, 8 2020.

Watch our Tutorial

Order Details

WytCote Antigen Order info

Available to Healthcare Professionals + Labs

Our SARS-CoV-2 Antigen test kit is only approved for sale to healthcare professionals and labs that have the appropriate licenses.

Study Validation

In a recent study, the SARS-CoV-2 Antigen detection specificity was perfect (100%) and sensitivity was 88% for patients who were tested at least two weeks from initial symptom onset.

Available to FDA EUA Markets

Inventory is readily available in the U.S. for direct shipments to healthcare customers within days of placing the order.

SARS-CoV-2 Antigen Test

The SARS-CoV-2 test kit is packaged with 20 test devices, 20 assay buffers, 20 extraction and vial caps and 20 specimen swabs. 

More Info

More Information on the Antigen Test Kit can be downloaded below:
Each box contains 20 kits.
Tests are ready to ship to you from within the U.S.
Tiered pricing available.
Or Call 1-877-472-5587 ext 5 Now!


Warning: This test has been authorized by FDA under an EUA for use by authorized laboratories.

This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

This product is intended for professional use and not for home use.

Not for the screening of donated blood.